| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 155.64B | 155.20B | 154.43B | 172.81B | 152.54B | 139.36B |
| Gross Profit | 45.45B | 44.94B | 42.70B | 49.28B | 42.11B | 38.77B |
| EBITDA | 27.31B | 28.55B | 29.49B | 33.62B | 26.34B | 17.29B |
| Net Income | 13.89B | 15.01B | 16.61B | 16.69B | 12.68B | 7.36B |
Balance Sheet | ||||||
| Total Assets | 289.67B | 288.10B | 290.49B | 251.35B | 245.59B | 227.97B |
| Cash, Cash Equivalents and Short-Term Investments | 22.51B | 22.24B | 22.21B | 18.51B | 17.95B | 19.30B |
| Total Debt | 58.26B | 50.30B | 48.99B | 32.38B | 39.91B | 39.14B |
| Total Liabilities | 101.52B | 99.99B | 101.02B | 80.39B | 87.28B | 78.77B |
| Stockholders Equity | 186.86B | 186.78B | 188.05B | 169.26B | 155.94B | 145.77B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 3.58B | -5.20B | 3.21B | 2.91B | 1.60B |
| Operating Cash Flow | 0.00 | 22.64B | 5.73B | 15.59B | 14.54B | 13.82B |
| Investing Cash Flow | 0.00 | -17.56B | -9.59B | -4.86B | -11.62B | -13.77B |
| Financing Cash Flow | 0.00 | -5.39B | 6.69B | -10.44B | -4.80B | 1.72B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | ¥857.06B | 14.76 | 19.69% | 3.15% | 10.06% | 18.03% | |
74 Outperform | ¥202.44B | 8.69 | ― | 4.09% | 1.69% | 0.94% | |
73 Outperform | ¥283.15B | 11.26 | 8.05% | 3.97% | 6.60% | 503.36% | |
69 Neutral | ¥337.36B | 10.96 | ― | 5.28% | -0.47% | 25.41% | |
66 Neutral | ¥760.52B | 10.74 | 4.79% | 4.21% | -1.21% | -27.21% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
60 Neutral | ¥324.97B | 36.21 | -4.00% | 3.71% | 0.24% | -234.36% |